Skip to main content
Livermore
Livermore
ZHEN

Baker Bros. Advisors LP

SEC CIK
0001263508
Latest filing
Aug 14, 2026

DSGN holding history

Design Therapeutics, Inc. in every 13F filed by Baker Bros. Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DSGN overviewAll 13F holders of DSGNFull Q2 2026 holdings

Shares (Q2 2026)
2,678,430
Value
$38.8M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of DSGN by Baker Bros. Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,678,430$38.8M0.2%+92,452+3.6%AddedHolders
Q1 20262,585,978$27.5M0.2%+352,879+15.8%AddedHolders
Q4 20252,233,099$20.9M0.1%+520,217+30.4%AddedHolders
Q3 20251,712,882$12.9M0.1%00.0%UnchangedHolders
Q2 20251,712,882$5.77M0.1%−30,843−1.8%ReducedHolders
Q1 20251,743,725$6.73M0.1%00.0%UnchangedHolders
Q4 20241,743,725$10.8M0.1%00.0%UnchangedHolders
Q3 20241,743,725$9.38M0.1%+48,431+2.9%AddedHolders
Q2 20241,695,294$5.68M0.1%+33,174+2.0%AddedHolders
Q1 20241,662,120$6.70M0.1%+162,120+10.8%AddedHolders
Q4 20231,500,000$3.98M<0.1%00.0%UnchangedHolders
Q3 20231,500,000$3.54M<0.1%+1,000,000+200.0%AddedHolders
Q2 2023500,000$3.15M<0.1%−126,884−20.2%ReducedHolders
Q1 2023626,884$3.62M<0.1%−65,247−9.4%ReducedHolders
Q4 2022692,131$7.10M<0.1%−744,505−51.8%ReducedHolders
Q3 20221,436,636$24.0M0.2%00.0%UnchangedHolders
Q2 20221,436,636$20.1M0.1%00.0%UnchangedHolders
Q1 20221,436,636$23.2M0.1%00.0%UnchangedHolders
Q4 20211,436,636$30.8M0.1%00.0%UnchangedHolders
Q3 20211,436,636$21.1M0.1%00.0%UnchangedHolders
Q2 20211,436,636$28.6M0.1%00.0%UnchangedHolders
Q1 20211,436,636$43.0M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.